Trial Of Pembrolizumab And Nintedanib

Clinical trial NCT02856425 · COMPLETED

Trial details

NCT number: NCT02856425
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Patients With Any Advanced Solid Tumors

Start date: 2016-11-10
Primary completion: 2025-01-10
Enrollment: 196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.